Advertisement

Cyanocobalamin Injection

[19 June 2014]

Products Affected - Description

Cyanocobalamin injection, American Regent
1000 mcg/mL, 1 mL vial (NDC 00517-0031-25)
1000 mcg/mL, 10 mL vial (NDC 00517-0032-25)
1000 mcg/mL, 30 mL vial (NDC 00517-0130-05)
 
Cyanocobalamin injection, Fresenius Kabi
1000 mcg/mL, 1 mL vial, NDC 63323-0044-01)

Reason for the Shortage

  • American Regent had temporarily suspended manufacture of most drug products including cyanocobalamin injection in April, 2011.
  • American Regent resumed manufacturing in Shirley, New York in early-May, 2011.
  • Fresenius Kabi (formerly APP) has cyanocobalamin injection on shortage due to increased demand for the product.     

Available Products

There is insufficient supply for usual ordering.

Estimated Resupply Dates

  • American Regent has cyanocobalamin 1000 mcg/mL 10 mL and 30 mL vials available but with expiration dates of August 2014 for the 10 mL vials and September 2014 for the 30 mL vials. The 1 mL vials are available in limited supply.
  • Fresenius Kabi has cyanocobalamin 1000 mcg/mL 1 mL vials on intermittent back order and the company is releasing product regularly.

Related Shortages

Updated

June 19, 2014; May 29, 2014; April 22, 2014; March 13, 2014; March 3, 2014; February 10, 2014; January 21, 2014; January 14, 2014; January 3, 2014; December 27, 2013; November 26, 2013; November 6, 2013; November 1, 2013; September 25, 2013; September 18, 2013; August 15, 2013; August 8, 2013; August 1, 2013; July 25, 2013; June 18, 2013; May 30, 2013; April 1, 2013; February 20, 2013; January 24, 2013; January 2, 2013; December 12, 2012; November 13, 2012; November 6, 2012; October 30, 2012; October 11, 2012; October 5, 2012; September 5, 2012; July 17, 2012; June 29, 2012; May 18, 2012; April 17, 2012; April 11, 2012; March 6, 2012; January 31, 2012; December 13, 2011; November 11, 2011; October 11, 2011; August 24, 2011; August 10, 2011; July 22, 2011; June 23, 2011; May 12, 2011; April 14, 2011, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement